Brian McEwan


Brian has a broad experience in pharmaceuticals ranging from multinationals to private entrepreneurial companies.


He helped create and grow the niche speciality pharma company Amdipharm which was bought by Cinven in Oct 2012 for £367M, staying in the business to merge Amdipharm and Mercury Pharma into AMCo.


He continues to consult for AMCo while building a portfolio of non-executive and advisory roles with companies that can benefit from his skills in strategy, communication, finance, business development and compliance.


BGF portfolio company: Abbey Pharma